A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
Condition:   Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Interventions:   Drug: fruquintinib;   Drug: Envafolimab Sponsor:   Shanghai 6th People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
Conditions:   Sarcoma,Soft Tissue;   Brachytherapy;   Poly(ADP-ribose) Polymerase Inhibitors Interventions:   Drug: Fluzoparib;   Procedure: Radioactive particle implantation Sponsor:   Fujun Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials